StonvexLoading…
StonvexStonvexStonvexCore line items from CXW's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $614.73M | $2.21B | $1.61B | $1.03B |
Operating Income | $52.31M | $157.18M | $120.91M | $84.35M |
Net Income | $37.92M | $116.50M | $89.97M | $38.54M |
EPS (Diluted) | $0.38 | $1.08 | $0.83 | $0.58 |
Total Assets | $3.37B | $3.26B | $3.11B | $3.07B |
Total Liabilities | $1.97B | $1.85B | $1.64B | $1.59B |
Cash & Equivalents | $209.69M | $97.93M | $56.55M | $130.52M |
Free Cash Flow OCF − CapEx | $-4.97M | $61.26M | $102.12M | $82.90M |
Shares Outstanding | 98.89M | 100.05M | 105.38M | 107.31M |